Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – Management of Toxicities from Immunotherapy

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Published online: 18 October 2022
J. Haanen, M. Obeid, L. Spain et al, on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline provides key recommendations for managing immunotherapy-related toxicity.
  • The guideline covers assessment, diagnosis and treatment of the most common and severe immunotherapy-related toxicities.
  • Recommended assessment and treatment algorithms according to the grade of toxicity are provided.
  • The authors comprise a multidisciplinary group of experts from different institutions in Europe, Australia and the USA.
  • Recommendations are based on available scientific data and the authors’ collective expert opinion.

ESMO Guidelines: Real World Cases - Webinar Series - Management of Immuno-Oncology Toxicities

ESMO-Guidelines-Real -World-Cases-Webinar-Series-General-1000x1000px

12 December 2023 at 18:30 CET

Join the experts developing and implementing the ESMO Guidelines

Register now

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.